{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T12:37:32Z","timestamp":1771072652925,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11-12","license":[{"start":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T00:00:00Z","timestamp":1698105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T00:00:00Z","timestamp":1698105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00508-023-02291-4","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T12:02:48Z","timestamp":1698148968000},"page":"331-339","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["FOXP3 expression in esophageal squamous cell carcinoma"],"prefix":"10.1007","volume":"136","author":[{"given":"Shenghong","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhonghui","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,24]]},"reference":[{"issue":"2","key":"2291_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen\u00a0W, Zheng\u00a0R, Baade\u00a0PD, et\u00a0al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115\u201332. https:\/\/doi.org\/10.3322\/caac.21338.","journal-title":"CA Cancer J Clin"},{"key":"2291_CR2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/s12885-015-1393-8","volume":"15","author":"D Jiang","year":"2015","unstructured":"Jiang\u00a0D, Li\u00a0X, Wang\u00a0H, et\u00a0al. The prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma. BMC Cancer. 2015;15:377. https:\/\/doi.org\/10.1186\/s12885-015-1393-8.","journal-title":"BMC Cancer"},{"issue":"8","key":"2291_CR3","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1111\/j.1572-0241.2005.50018.x","volume":"100","author":"ZD Gu","year":"2005","unstructured":"Gu\u00a0ZD, Li\u00a0JY, Li\u00a0M, et\u00a0al. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma. Am J Gastroenterol. 2005;100(8):1835\u201343. https:\/\/doi.org\/10.1111\/j.1572-0241.2005.50018.x. Erratum in: Am J Gastroenterol. 2006 Sep;101(9):2171.","journal-title":"Am J Gastroenterol"},{"issue":"7498","key":"2291_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature13176","volume":"509","author":"Y Song","year":"2014","unstructured":"Song\u00a0Y, Li\u00a0L, Ou\u00a0Y, et\u00a0al. Identification of genomic alterations in oesophageal squamous cell cancer. Nature. 2014;509(7498):91\u20135. https:\/\/doi.org\/10.1038\/nature13176.","journal-title":"Nature"},{"key":"2291_CR5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.radonc.2019.01.013","volume":"134","author":"B Brenner","year":"2019","unstructured":"Brenner\u00a0B, Purim\u00a0O, Gordon\u00a0N, et\u00a0al. The addition of cetuximab to preoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma is associated with high rate of long term survival: Mature results from a\u00a0prospective phase\u00a0Ib\/II trial. Radiother Oncol. 2019;134:74\u201380. https:\/\/doi.org\/10.1016\/j.radonc.2019.01.013.","journal-title":"Radiother Oncol"},{"issue":"6","key":"2291_CR6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nri3464","volume":"13","author":"S Sakaguchi","year":"2013","unstructured":"Sakaguchi\u00a0S, Vignali\u00a0DA, Rudensky\u00a0AY, et\u00a0al. The plasticity and stability of regulatory T\u00a0cells. Nat Rev Immunol. 2013;13(6):461\u20137. https:\/\/doi.org\/10.1038\/nri3464.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"2291_CR7","first-page":"8717","volume":"8","author":"Q Luo","year":"2015","unstructured":"Luo\u00a0Q, Zhang\u00a0S, Wei\u00a0H, et\u00a0al. Roles of Foxp3 in the occurrence and development of cervical cancer. Int J Clin Exp Pathol. 2015;8(8):8717\u201330.","journal-title":"Int J Clin Exp Pathol"},{"issue":"50","key":"2291_CR8","doi-asserted-by":"publisher","first-page":"e32102","DOI":"10.1097\/MD.0000000000032102","volume":"101","author":"J Zhu","year":"2022","unstructured":"Zhu\u00a0J, Li\u00a0Z, Chen\u00a0J, et\u00a0al. A\u00a0comprehensive bioinformatics analysis of FOXP3 in nonsmall cell lung cancer. Medicine. 2022;101(50):e32102. https:\/\/doi.org\/10.1097\/MD.0000000000032102.","journal-title":"Medicine"},{"issue":"2","key":"2291_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/0394632017710415","volume":"30","author":"X Sun","year":"2017","unstructured":"Sun\u00a0X, Feng\u00a0Z, Wang\u00a0Y, et\u00a0al. Expression of Foxp3 and its prognostic significance in colorectal cancer. Int J Immunopathol Pharmacol. 2017;30(2):201\u20136. https:\/\/doi.org\/10.1177\/0394632017710415.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"2","key":"2291_CR10","first-page":"1792","volume":"8","author":"B Zhang","year":"2015","unstructured":"Zhang\u00a0B, Dou\u00a0Y, Xu\u00a0X, et\u00a0al. Endogenous FOXP3 inhibits cell proliferation, migration and invasion in glioma cells. Int J Clin Exp Med. 2015;8(2):1792\u2013802.","journal-title":"Int J Clin Exp Med"},{"issue":"7","key":"2291_CR11","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1158\/0008-5472.CAN-18-2049","volume":"79","author":"L Wu","year":"2019","unstructured":"Wu\u00a0L, Yi\u00a0B, Wei\u00a0S, et al. Loss of FOXP3 and TSC1 accelerates prostate cancer progression through synergistic transcriptional and posttranslational regulation of c\u2011MYC. Cancer Res. 2019;79(7):1413\u201325. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-2049.","journal-title":"Cancer Res"},{"key":"2291_CR12","doi-asserted-by":"publisher","first-page":"656190","DOI":"10.3389\/fonc.2021.656190","volume":"11","author":"C Liu","year":"2021","unstructured":"Liu\u00a0C, Han\u00a0J, Li\u00a0X, et\u00a0al. FOXP3 inhibits the metastasis of breast cancer by downregulating the expression of MTA1. Front Oncol. 2021;11:656190. https:\/\/doi.org\/10.3389\/fonc.2021.656190.","journal-title":"Front Oncol"},{"issue":"40","key":"2291_CR13","doi-asserted-by":"publisher","first-page":"21085","DOI":"10.1074\/jbc.M116.717892","volume":"291","author":"S Wang","year":"2016","unstructured":"Wang\u00a0S, Zhang\u00a0Y, Wang\u00a0Y, et al. Amphiregulin confers regulatory T\u00a0cell suppressive function and tumor invasion via the EGFR\/GSK-3\u03b2\/Foxp3 axis. J\u00a0Biol Chem. 2016;291(40):21085\u201395. https:\/\/doi.org\/10.1074\/jbc.M116.717892.","journal-title":"J Biol Chem"},{"issue":"4","key":"2291_CR14","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot\u00a0JD, Gavin\u00a0MA, Rudensky\u00a0AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T\u00a0cells. Nat Immunol. 2003;4(4):330\u20136. https:\/\/doi.org\/10.1038\/ni904.","journal-title":"Nat Immunol"},{"issue":"7","key":"2291_CR15","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nri2785","volume":"10","author":"S Sakaguchi","year":"2010","unstructured":"Sakaguchi\u00a0S, Miyara\u00a0M, Costantino\u00a0CM, et\u00a0al. FOXP3+ regulatory T\u00a0cells in the human immune system. Nat Rev Immunol. 2010;10(7):490\u2013500. https:\/\/doi.org\/10.1038\/nri2785.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2291_CR16","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1442-2050.2009.01013.x","volume":"23","author":"L Xue","year":"2010","unstructured":"Xue\u00a0L, Lu\u00a0HQ, He\u00a0J, et\u00a0al. Expression of FOXP3 in esophageal squamous cell carcinoma relating to the clinical data. Dis Esophagus. 2010;23(4):340\u20136. https:\/\/doi.org\/10.1111\/j.1442-2050.2009.01013.x.","journal-title":"Dis Esophagus"},{"issue":"119","key":"2291_CR17","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.5754\/hge11961","volume":"59","author":"G Wang","year":"2012","unstructured":"Wang\u00a0G, Liu\u00a0G, Liu\u00a0Y, et\u00a0al. FOXP3 expression in esophageal cancer cells is associated with poor prognosis in esophageal cancer. Hepatogastroenterology. 2012;59(119):2186\u201391. https:\/\/doi.org\/10.5754\/hge11961.","journal-title":"Hepatogastroenterology"},{"issue":"5","key":"2291_CR18","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3892\/mmr.2012.1066","volume":"6","author":"C Li","year":"2012","unstructured":"Li\u00a0C, Yang\u00a0W, Gai\u00a0X, Zhang\u00a0Y, et\u00a0al. Foxp3 overexpression decreases sensitivity to chemotherapy in mouse Lewis lung cancer cells. Mol Med Rep. 2012;6(5):977\u201382. https:\/\/doi.org\/10.3892\/mmr.2012.1066.","journal-title":"Mol Med Rep"},{"issue":"124","key":"2291_CR19","doi-asserted-by":"publisher","first-page":"704","DOI":"10.5754\/hge12953","volume":"60","author":"G Wang","year":"2013","unstructured":"Wang\u00a0G, Sun\u00a0Y, Ji\u00a0C, et\u00a0al. Correlation between the CD4+CD25high regulatory T\u00a0cells and the outcome of chemotherapy in advanced esophageal carcinoma. Hepatogastroenterology. 2013;60(124):704\u20138. https:\/\/doi.org\/10.5754\/hge12953.","journal-title":"Hepatogastroenterology"},{"issue":"2","key":"2291_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s12013-011-9197-1","volume":"61","author":"T Xu","year":"2011","unstructured":"Xu\u00a0T, Duan\u00a0Q, Wang\u00a0G, et\u00a0al. CD4 + CD25high regulatory T\u00a0cell numbers and FOXP3 mRNA expression in patients with advanced esophageal cancer before and after chemotherapy. Cell Biochem Biophys. 2011;61(2):389\u201392. https:\/\/doi.org\/10.1007\/s12013-011-9197-1.","journal-title":"Cell Biochem Biophys"},{"issue":"10","key":"2291_CR21","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.prp.2017.09.004","volume":"213","author":"C Li","year":"2017","unstructured":"Li\u00a0C, Sun\u00a0L, Jiang\u00a0R, et\u00a0al. Downregulation of FOXP3 inhibits cell proliferation and enhances chemosensitivity to cisplatin in human lung adenocarcinoma. Pathol Res Pract. 2017;213(10):1251\u20136. https:\/\/doi.org\/10.1016\/j.prp.2017.09.004.","journal-title":"Pathol Res Pract"},{"issue":"2","key":"2291_CR22","doi-asserted-by":"publisher","first-page":"e20191009","DOI":"10.1084\/jem.20191009","volume":"217","author":"A Tanaka","year":"2020","unstructured":"Tanaka\u00a0A, Nishikawa\u00a0H, Noguchi\u00a0S, et\u00a0al. Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T\u00a0cells. J\u00a0Exp Med. 2020;217(2):e20191009. https:\/\/doi.org\/10.1084\/jem.20191009.","journal-title":"J Exp Med"},{"issue":"8","key":"2291_CR23","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1158\/1078-0432.CCR-19-2027","volume":"26","author":"K Isomoto","year":"2020","unstructured":"Isomoto\u00a0K, Haratani\u00a0K, Hayashi\u00a0H, et al. Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in EGFR Mutation-Positive Non-Small Cell Lung Cancer. Clin Cancer Res. 2020;26(8):2037\u201346. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2027.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2291_CR24","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S1470-2045(21)00136-4","volume":"22","author":"AG Sacco","year":"2021","unstructured":"Sacco\u00a0AG, Chen\u00a0R, Worden\u00a0FP, et al. Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase\u00a02\u00a0trial. Lancet Oncol. 2021;22(6):883\u201392. https:\/\/doi.org\/10.1016\/S1470-2045(21)00136-4.","journal-title":"Lancet Oncol"},{"issue":"11","key":"2291_CR25","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1158\/1078-0432.CCR-21-3849","volume":"28","author":"CH Chung","year":"2022","unstructured":"Chung\u00a0CH, Li\u00a0J, Steuer\u00a0CE, et al. Phase\u00a0II multi-institutional clinical trial result of concurrent cetuximab and nivolumab in recurrent and\/or metastatic head and neck squamous cell carcinoma. Clin Cancer Res. 2022;28(11):2329\u201338. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-3849.","journal-title":"Clin Cancer Res"},{"issue":"7738","key":"2291_CR26","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41586-018-0824-5","volume":"565","author":"M Ito","year":"2019","unstructured":"Ito\u00a0M, Komai\u00a0K, Mise-Omata\u00a0S, et al. Brain regulatory T\u00a0cells suppress astrogliosis and potentiate neurological recovery. Nature. 2019;565(7738):246\u201350. https:\/\/doi.org\/10.1038\/s41586-018-0824-5.","journal-title":"Nature"},{"key":"2291_CR27","doi-asserted-by":"publisher","first-page":"15129","DOI":"10.1038\/ncomms15129","volume":"8","author":"R Jiang","year":"2017","unstructured":"Jiang\u00a0R, Tang\u00a0J, Chen\u00a0Y, et al. The long noncoding RNA lnc-EGFR stimulates T\u2011regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion. Nat Commun. 2017;8:15129. https:\/\/doi.org\/10.1038\/ncomms15129.","journal-title":"Nat Commun"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-023-02291-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-023-02291-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-023-02291-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T09:15:38Z","timestamp":1717665338000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-023-02291-4"}},"subtitle":["Implications for cetuximab sensitivity and therapeutic strategies"],"short-title":[],"issued":{"date-parts":[[2023,10,24]]},"references-count":27,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2291"],"URL":"https:\/\/doi.org\/10.1007\/s00508-023-02291-4","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,24]]},"assertion":[{"value":"20 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.\u00a0Wu, Y.\u00a0Wang, Z.\u00a0Xiao, J.\u00a0Zhang, Z.\u00a0He and M.\u00a0Ye declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The current study was approved by the Animal Ethics Committee and was conducted in accordance with the relevant agreements with Renji Hospital. All procedures were performed in accordance with the Guidance Suggestions for the Care and Use of Laboratory Animals, formulated by the Ministry of Science and Technology of China. Consent for Publication: not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}